Glaukos (GKOS) Other Non-Current Assets (2018 - 2026)
Glaukos' (GKOS) quarterly Other Non-Current Assets came in at $3.8 million in Q1 2026, down 18.99% year-on-year from $4.7 million in Q1 2025, and little changed on a QoQ basis from $3.8 million in Q4 2025.
Glaukos (GKOS) Other Non-Current Assets (2018 - 2026) Analysis & Trends
Glaukos (GKOS) has 9 years of Other Non-Current Assets data on file, last reported at $3.8 million in Q1 2026.
- On a quarterly basis, Other Non-Current Assets fell 18.99% year-over-year to $3.8 million in Q1 2026; TTM through Mar 2026 was $3.8 million, a 18.99% decrease from a year earlier, with the FY2025 full-year figure at $3.8 million, down 18.99% from the prior year.
- Other Non-Current Assets for Q1 2026 stood at $3.8 million, roughly flat from $3.8 million in the prior quarter.
- Over the last five years, Other Non-Current Assets for GKOS reached as high as $9.4 million in Q1 2022 and fell as low as $3.8 million in Q2 2025.
- Historically, Other Non-Current Assets has averaged $5.9 million across 5 years, with a median of $5.9 million in 2023.
- Across the five-year window, Other Non-Current Assets changed 0.0% in 2022 and tumbled 35.85% in 2023, its largest moves.
- Year by year, Other Non-Current Assets stood at $7.1 million in 2022, then retreated by 17.26% to $5.9 million in 2023, then declined by 19.18% to $4.7 million in 2024, then retreated by 18.99% to $3.8 million in 2025, then changed by 0.0% to $3.8 million in 2026.
- Per Business Quant data, the three most recent Other Non-Current Assets figures were $3.8 million in Q1 2026, $3.8 million in Q4 2025, and $3.8 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | - |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 3.17 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 4.15 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 2.05 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 738.90 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 285.90 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 828.89 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 2.25 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 164.00 Mn |
| 10 | Glaukos | 8.83 Bn | 8.73 Bn | 117.23 Mn | 3.83 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.83 Mn |
| Dec 31, 2025 | 3.83 Mn |
| Sep 30, 2025 | 3.83 Mn |
| Jun 30, 2025 | 3.83 Mn |
| Mar 31, 2025 | 4.73 Mn |
| Dec 31, 2024 | 4.73 Mn |
| Sep 30, 2024 | 4.73 Mn |
| Jun 30, 2024 | 4.73 Mn |
| Mar 31, 2024 | 5.86 Mn |
| Dec 31, 2023 | 5.86 Mn |
| Sep 30, 2023 | 5.86 Mn |
| Jun 30, 2023 | 5.86 Mn |
| Mar 31, 2023 | 7.08 Mn |
| Dec 31, 2022 | 7.08 Mn |
| Sep 30, 2022 | 9.08 Mn |
| Jun 30, 2022 | 9.13 Mn |
| Mar 31, 2022 | 9.42 Mn |
| Dec 31, 2021 | 9.42 Mn |
| Sep 30, 2021 | 9.42 Mn |
| Jun 30, 2021 | 9.42 Mn |